INTERNATIONAL PATENT: FORTVITA BIOLOGICS INC. FILES APPLICATION FOR "GLP-1 RECEPTOR TARGETING COMPOUNDS AND USES THEREOF"

GENEVA, June 16 -- FORTVITA BIOLOGICS INC. (Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205) filed a patent application (PCT/CN2024/136693) for "GLP-1 RECEPTOR TARGETING COMPOUNDS AND USES THEREOF" on Dec 04, 2024. With publication no. WO/2025/119206, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Lianhong (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), YU, Nan (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), REN, ...